76 Participants Needed

Education Program for Breast Cancer

AP
AP
Overseen ByAnn Patridge, MD, MPH
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Dana-Farber Cancer Institute
Must be taking: Endocrine therapy
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This research is being done to pilot an intervention which aims to improve participants' experiences on Endocrine Therapy.The name of the intervention used in this research study is:Endocrine Therapy Education Program (a brief, video-based intervention)

Who Is on the Research Team?

AP

Ann Partridge, MD, MPH

Principal Investigator

Dana-Farber Cancer Institute

Are You a Good Fit for This Trial?

This trial is for individuals with breast cancer who are undergoing or about to start endocrine therapy. The study aims to help participants better understand and adhere to their treatment regimen.

Inclusion Criteria

Computer literacy (ability to watch videos and fill out questionnaires online)
English fluency for reading and writing
I am biologically female.
See 1 more

Exclusion Criteria

I am unable to give consent for myself.
Prisoners
Pregnant women
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Baseline

Participants complete a baseline visit and initial assessments

1 week
1 visit (in-person)

Intervention

Participants in Group A receive educational video once a week for 6 weeks; Group B waits for access

6 weeks
Weekly video sessions

Follow-up

Participants complete surveys at 6 weeks and 3 months to assess intervention impact

6 weeks
2 surveys (virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • Endocrine Therapy Education Program
Trial Overview The focus of the trial is on a video-based Endocrine Therapy Education Program designed to enhance patients' understanding of their therapy, potentially improving adherence and overall experience.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Group A: Endocrine Therapy Education InterventionExperimental Treatment1 Intervention
Participants will complete: * Baseline visit. * Educational video once a week for 6 weeks. * 6-week survey. * 3-month survey.
Group II: Group B: Wait-List Control GroupActive Control1 Intervention
Participants will complete: * Baseline visit. * 6-week survey. * 3-month survey. * Access to intervention educational videos. * 2-week post video survey.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Dana-Farber Cancer Institute

Lead Sponsor

Trials
1,128
Recruited
382,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security